Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;25(6):536-544.
doi: 10.1097/MNH.0000000000000280.

Cardiovascular complications in chronic dialysis patients

Thomas A Mavrakanas  1 , David M Charytan
Affiliations
Review

Cardiovascular complications in chronic dialysis patients

Thomas A Mavrakanas et al. Curr Opin Nephrol Hypertens. 2016 Nov.

Abstract

Purpose of review: This review article focuses on the most significant cardiovascular complications in dialysis patients [sudden cardiac death (SCD), acute coronary syndromes, heart failure, and atrial fibrillation].

Recent findings: Current and ongoing research aims to quantify the rate and pattern of significant arrhythmia in dialysis patients and to determine the predominant mechanism of SCD. Preliminary findings from these studies suggest a high rate of atrial fibrillation and that bradycardia and asystole may be more frequent than ventricular arrhythmia as a cause of sudden death. A recently published matched cohort study in dialysis patients who received a defibrillator for primary prevention showed that there was no significant difference in mortality rates between defibrillator-treated patients and propensity-matched controls. Two randomized controlled trials are currently recruiting participants and will hopefully answer the question of whether implantable or wearable cardioverter defibrillators can prevent SCD. An observational study using United States Renal Data System data demonstrated how difficult it is to keep hemodialysis patients on warfarin, as more than two-thirds discontinued the drug during the first year. The ISCHEMIA-CKD trial may provide answers about the optimal strategy for the treatment of atherosclerotic coronary disease in patients with advanced chronic kidney disease.

Summary: The article reviews the diagnosis of acute coronary syndromes in dialysis patients, current literature on myocardial revascularization, and data on fatal and nonfatal cardiac arrhythmia. The new classification of heart failure in end-stage renal disease is reviewed. Finally, available cohort studies on warfarin for stroke prevention in dialysis patients with atrial fibrillation are reviewed.

PubMed Disclaimer

Conflict of interest statement

Dr. Charytan has received research funding from Medtronic and Janssen pharmaceuticals for work on the MiD and CREDENCE trials, consulting fees from Zoll Medical for work on the steering committee of the WEDHEAD trial and consulting fees from Medtronic.

Figures

Figure 1
Figure 1
(previously published). Survival of patients who received an implantable cardioverter defibrillator for secondary prevention compared with matched cohort. Full source details: Figure 2, page 413 from Charytan DM, Patrick AR, Liu J, et al. Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011; 58:409–417.
See this image and copyright information in PMC

References

    1. Passman R, Herzog CA. Sudden cardiac death: stratifying risk in dialysis patients. Nat Rev Nephrol. 2011;7:133–135. - PubMed
    1. US Renal Data system. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End Stage Renal Disease in the United States, national institutes of Health, national institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, USA: 2010.
    1. Wheeler DC, London GM, Parfrey PS, et al. Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. J Am Heart Assoc. 2014;3:e001363. - PMC - PubMed
    1. Drechsler C, Grootendorst DC, Pilz S, et al. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie) Am J Kidney Dis. 2011;58:599–607. - PubMed
    1. Parekh RS, Plantinga LC, Kao WH, et al. The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int. 2008;74:1335–1342. - PubMed

MeSH terms